Vanessa Bryant

Appearances

GLUTEN-SPECIFIC CD4+ T CELL DETECTION USING A WHOLE BLOOD INTERLEUKIN-2 RELEASE ASSAY IS SENSITIVE AND SPECIFIC FOR CELIAC DISEASE
Date
May 19, 2024
BACKGROUND: Celiac disease (CeD) is prevalent but frequently undiagnosed. Central to its pathogenesis are proinflammatory HLA-DQ-restricted gluten-specific CD4+ T cells in the intestine and circulation…
Presenter
Olivia Moscatelli
Speakers
Amy Russell
Lee Henneken
Linda Fothergill
Vanessa Bryant
Jason Tye-Din
A WHOLE BLOOD INTERLEUKIN-2 RELEASE ASSAY OFFERS HIGHER SENSITIVITY TO DETECT GLUTEN-SPECIFIC CD4+ T CELLS THAN INTERFERON-γ ELISPOT IN CELIAC DISEASE AND ACCURATELY REFLECTS GLUTEN PEPTIDE IMMUNOGENICITY
Date
May 20, 2024
INTRODUCTION: Celiac disease (CeD) is caused by proinflammatory gluten-specific CD4+ T cells that reside in the small intestine and circulation at low frequency…
Presenter
Olivia Moscatelli
Speakers
Amy Russell
Lee Henneken
Linda Fothergill
Vanessa Bryant
Jason Tye-Din